3 Summary of contribution
Formulation Parameter Volume, V10(ml) Sample conc, C10  (M) Mass samplemsample(kg) Recovery method Repeatability
Tablet Value 10 4.376 ×10-8 1.00 ×10-4 101 ×10-2 ----
Standard uncertainity, u(x) 5.56 ×10-3 3.99 ×10-9 4.49 ×10-5 2.85 ×10-2 8.4 ×10-2
RSU*, u(x)/x 5.56 ×10-4 9.98 ×10-5 0.277 2.82 ×10-2 8.4 ×10-2
Table 6: Summary of contribution to the measurement uncertainty for determination of cilostazol through RP-HPLC in tablet dosage form.